News
HST Collects relevant news from a variety of sources, for your convenience. Select a story from below, or use our search feature to find stories of interest.

Aspen wins ARV tender
IOL
2008-06-27

Aspen has won a significant portion of the tender for the supply of anti-retrovirals (ARVs) to the department of health, the pharmaceutical manufacturer announced on Thursday.

The results reflect positively on our competitiveness, breadth of our product offering and on the effectiveness of our service delivery, said Aspen Group chief executive Stephen Saad. The tender was effective for a period of two years, commencing retrospectively from June 1 2008, Aspen said.

In addition to maintaining the supply contract for existing tender items, Aspen has also secured volumes for two new products, Aspen Efavirenz and Tenofivir. The South African ARV tender is the largest of its kind in the world and since inception, Aspen has been the major supplier to this programme.

With the growing number of HIV and AIDS patients under treatment, the actual volumes supplied to the government during the last tender had continued to show incremental growth each month, the company said. Aspen had been able to respond to this growth in demand, it said. Products are manufactured at the company's facility in Port Elizabeth. Recent investments have been made in extending manufacturing capability and upgrading existing facilities. This has resulted in unlocking capacity and ensuring that demand requirements are met, the company said.

Keywords	This Item is associated with the Following Keywords: .
You Can Comment on this Item, or View other people's Comments
Easy Print  Email to a friend